As we mark our birthday virtually this year against the backdrop of the current pandemic, we’d like to thank all of our amazing OBH supporters, advisors and friends who’ve been part of our exciting journey measuring what matters most in health over past 7 years! Here are a few highlights from what has definitely been the busiest (and more recently, the most unpredictable!) year yet…. including the prospect of potentially taking on some clinical work again amongst the data analytics work for some of us.
Over the past 12 months, OBH have been working with NHS England on the implementation of an actionable, common, data-driven approach to population segmentation. In collaboration with NHS Arden and GEM Commissioning Support Unit and the Data, Analysis and Intelligence Service (DAIS) at NHSE/I, the programme of work seeks to build a common framework for segmentation by developing the ‘Bridges to Health’ segmentation model using data sources from the National Commissioning Data Repository (NCDR).
Building on the solid foundations of this person-centred data model, over the past few weeks we’ve been very busy adjusting the model to address the immediate needs of the COVID-19 pandemic response. This aims to support work to establish the populations currently thought to be most ‘vulnerable’ to severe illness from COVID -19. Find out more here.
Back in February, which already seems like a completely different era, we were delighted to have contributed to the APPG ‘The Health of the Nation’ national strategy for #HealthierLongerLives! We look forward to continuing to support this important work, applying OBH’s objective HealthSpan™ and HealthyLifespan® Index at a population level to meet the government’s mission of five extra healthy years by 2035. Given recent events, ensuring a renewed focus on the prevention of ill-health, whilst narrowing the gap between the richest and the poorest seems more urgent than ever. Read the full report here.
Having been selected to participate in the Health Data Research UK Sandbox in September 2019, we look forward to continuing this work involving the use of linked, longitudinal health data to measure and validate OBH’s HealthSpan™ and HealthyLifespan® index measures throughout the future. Find out more here.
And last but not least, we had a great time hosting our second clinical associates network event at the Health Foundry back in October! It was fantastic to see so many members of the #obhnetwork community and welcome some new faces too.
Despite current events, we look forward to seeing what the next year has to hold in what we hope will be a slightly less strange time for everyone! From everyone in the OBH team, we’d like to thank you again for all your support over the past 7 years. We hope you, your families and colleagues keep safe and well.
#OBHis7 #outcomes #healthspan
Nasrin Hafezparast
Co-Founder and CTO Dr Nasrin Hafezparast is co-founder and CTO at OBH. She is dual trained in both Computer Science and Medicine, both at University College London. As a fully qualified medical doctor, she has experience working as a doctor in A&E, General Practice and Hospital Medicine in London. Nasrin has an entrepreneurial background and skill set. She is a Teaching Fellow and co-leads the healthcare pathway in the MSc Technology Entrepreneurship at UCL, and is an Advisory Board member of Reform, the independent think-tank. She was selected by Management Today as one of ’35 women under 35′, and selected as one of ‘Twenty women in data & tech’ by The Female Lead and Women in Tech. She spoke at TEDxTehran on ‘Breaking through the disease barrier’. In addition, her interest in technology led her to co-found a website design and development agency in 2004 where she explored the online tech space and continues to manage a successful online B2B venture today. Nasrin brings an invaluable combination of technology and healthcare experience to OBH’s technical and process work on outcomes measurement. She has an extensive understanding and background in clinical and health datasets, and patient-reported data. Harvard Business School Value-Based Healthcare Delivery alumnus.
